1-Hydroxybenzotriazole → HCID 178430552, compound
Reaction equation
[CH3:1][C:2]1[C:3]([CH2:9][N:10]([CH2:28][C:29]2[C:34]([CH:35]([CH3:37])[CH3:36])=[CH:33][CH:32]=[CH:31][N:30]=2)[CH2:11][CH2:12][C:13]2[N:14]=[CH:15][N:16](S(C3C=CC(C)=CC=3)(=O)=O)[CH:17]=2)=[N:4][CH:5]=[C:6]([CH3:8])[CH:7]=1.C1C=CC2N(O)N=NC=2C=1>CO>[CH3:1][C:2]1[C:3]([CH2:9][N:10]([CH2:11][CH2:12][C:13]2[N:14]=[CH:15][NH:16][CH:17]=2)[CH2:28][C:29]2[C:34]([CH:35]([CH3:37])[CH3:36])=[CH:33][CH:32]=[CH:31][N:30]=2)=[N:4][CH:5]=[C:6]([CH3:8])[CH:7]=1Participants
Procedure
To a solution of (3,5-dimethyl-pyridin-2-ylmethyl)-(3-isopropyl-pyridin-2-ylmethyl)-{2-[1-(toluene-4-sulfonyl)-1H-imidazol-4-yl]-ethyl}-amine (99.1 mg, 0.19 mmol) in anhydrous MeOH (1.5 mL) was added HOBT (108.5 mg, 0.803 mmol) and the resulting mixture was stirred overnight. The mixture was concentrated and purified by radial chromatography on silica gel (1 mm plate; using 6% MeOH/CH2Cl2, followed by CH2Cl2/MeOH/NH4OH; 17:1:1) to afford COMPOUND 176 as a light brown oil (43.4 mg, 62%). 1H NMR (CDCl3) δ 1.00 (d, 6H, J=9.0 Hz), 2.07 (s, 3H), 2.21 (s, 3H), 2.86 (s, 4H), 3.09 (qnt, 1H, J=6.0 Hz), 3.77 (s, 2H), 3.84 (s, 2H), 6.70 (s, 1H}, 7.11 (m, 2H), 7.43 (d, 1H, J=7.8 Hz), 7.57 (s, 1H), 8.14 (s, 1H), 8.32 (d, 1H, J=4.7 Hz). 13C NMR (CDCl3) δ 18.2, 18.3, 23.0, 23.5, 27.8, 54.8, 57.6, 58.2, 123.0, 124.4, 130.4, 132.0, 132.6, 133.6, 134.9, 139.1, 143.6, 145.8 146.3, 153.9, 155.7. ES-MS m/z 364 [M+H]+. Anal. Calcd. for C22H29N5.0.6H2O.0.1 CH2Cl2: C, 72.69; H, 8.04; N, 19.27. Found: C, 69.46; H, 8.11; N, 18.24.
Workup
- concentrationThe mixture was concentrated
- custompurified by radial chromatography on silica gel (1 mm plate; using 6% MeOH/CH2Cl2, followed by CH2Cl2/MeOH/NH4OH; 17:1:1)
Sources & evidence
- ORD record
- ord-10a8f6752ce84d908dc6bf091bdddcb8
- Source dataset
- uspto-grants-2007_11
- Patent number
- US07291631B2
Reaction notes
Loading…